Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities:    
Net income from continuing operations $ 77,894 $ 37,634
Adjustments to reconcile net income of continuing operations to net cash provided by operating activities of continuing operations    
Depreciation and amortization 28,067 27,919
Change in fair value of earn-out liability (385) (2,209)
Share-based compensation expense 8,179 7,852
Provision for revenue adjustments 5,504 2,972
Deferred income tax (benefit) expense (1,384) 4,317
Other 406 714
Changes in operating assets and liabilities, net of effects from the purchase of acquired businesses:    
Accounts receivable (49,086) (20,436)
Other receivables (14,218) 0
Other current and noncurrent assets 8,198 1,253
Accounts payable and accrued expenses 19,577 20,477
Net cash provided by operating activities of continuing operations 82,752 80,493
Investing activities:    
Proceeds from sale of property and equipment 2,339 1,415
Purchases of property and equipment (23,015) (16,439)
Purchase of a business, net of cash acquired (23,053) (55,931)
Net cash used in investing activities of continuing operations (43,729) (70,955)
Financing activities:    
Repayments of finance lease obligations (1,445) (529)
Proceeds from revolving credit facility 45,000 65,000
Payments on revolving credit facility 0 (20,000)
Payment of debt issuance costs (119) 0
Payment of earn-out liability (6,519) (5,284)
Proceeds from issuance of common stock upon stock option exercises 3,563 1,901
Payments of dividends to shareholders (17,270) (15,090)
Repurchases and retirement of common stock (48,989) (45,248)
Proceeds from common stock issued under employee stock purchase plan 388 294
Payment of minimum tax withholdings on share-based awards (3,074) (3,444)
Contributions from (distributions to) subsidiary held for sale 1,118  
Contributions from (distributions to) subsidiary held for sale   (8,897)
Net cash used in financing activities from continuing operations (27,347) (31,297)
Net increase (decrease) in cash and cash equivalents of continuing operations 11,676 (21,759)
Cash from discontinued operation:    
Net cash used in operating activities of discontinued operation (6,902) (8,090)
Net cash provided by (used in) investing activities of discontinued operation 8,020 (807)
Net cash (used in) provided by financing activities of discontinued operation (1,118) 8,897
Net increase (decrease) in cash and cash equivalents 11,676 (21,759)
Cash and cash equivalents at beginning of period of continuing operations 40,254 64,749
Cash at beginning of period of discontinued operation 0 0
Less: cash at end of period of discontinued operation 0 0
Cash and cash equivalents at end of period of continuing operations $ 51,930 $ 42,990